The modulation of choline phosphoglyceride metabolism in human colon cancer

• Published in: Molecular and cellular biochemistry 1996-09, Vol.162 (2), p.97-103
• Main Authors: Dueck, D A, Chan, M, Tran, K, Wong, J T, Jay, F T, Littman, C, Stimpson, R, Choy, P C
• Format: Article
• Language: English
• Subjects: Colon - enzymology; Colon - metabolism; Colon - pathology; Colonic Neoplasms - enzymology; Colonic Neoplasms - metabolism; Colonic Neoplasms - pathology; Humans; Intestinal Mucosa - metabolism; Intestinal Mucosa - pathology; Nucleotidyltransferases - metabolism; Phosphatidylcholines - metabolism; Phospholipids - metabolism
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/bf00227535

Colorectal cancer has a high incidence of morbidity and mortality in the North American population. Elevated levels of plasmalogens have been reported in some neoplastic tissues including colon tumors, but the mechanism for this increase has not been defined. Since changes in plasmalogen level are usually associated with changes in the other phospholipid subclasses, a general increase in all phospholipid subclasses may also be found in colonic neoplasms. In this study, the levels of the major phospholipids, including their plasmalogen and diacylphospholipid subclasses, were found to be elevated in human malignant colonic tissues. Since phosphatidylcholine is the most prominent type of phospholipid found in both malignant and control tissues, the mechanism for its accumulation during malignancy was investigated. Decreases in phospholipase C and D activities were observed in tumor samples, but an enhancement of the CTP: phosphocholine cytidylyltransferase activity was also detected. Immunoblotting analysis revealed that the elevated cytidylyltransferase activity was caused by a three-fold increase in the level of enzyme protein during tumor development. Based on these enzyme studies, we conclude that the high level of phosphatidylcholine in colon tumors resulted from a decrease in its turnover and an increase in its expression.